Repligen Corporation (FRA:RGN)

Germany flag Germany · Delayed Price · Currency is EUR
139.75
+6.05 (4.53%)
Last updated: Nov 24, 2025, 8:09 AM CET
1.05%
Market Cap8.30B
Revenue (ttm)603.33M
Net Income (ttm)1.48M
Shares Outn/a
EPS (ttm)0.02
PE Ratio5,604.68
Forward PE89.13
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume27
Open139.75
Previous Close133.70
Day's Range139.75 - 139.75
52-Week Range94.12 - 170.00
Betan/a
RSI66.17
Earnings DateFeb 19, 2026

About Repligen

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1981
Employees 1,778
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol RGN
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.